PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

if you look at the data behind it, you'll find that the...

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    if you look at the data behind it, you'll find that the change (volume) wasn't significant in a stastistical sense. nice picture but nothing conclusive. A number of studies suggest BMLs heal by themselves without treatment so having a time lapse with a reduction on BML isnt convincing. beware any presentation from the company around that time, not sure if they have achieved any milestones they had set out to achieve yet. Dyor
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.